Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Soligenix Inc
SNGX
Healthcare
Biotechnology
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics segment is developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe...
visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Development programs in this segment also include expansion of synthetic hypericin (SGX302) into psoriasis and dusquetide (SGX942 and SGX945) for the treatment of inflammatory diseases. Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SNGX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 24, 2024 4:27pm
@ the Bell: Industrials weakness snaps TSX win streak
Industrials led decliners, followed by financials, to snap the TSX’s five-day win streak while energy, utilities and mining provided gains.
read article.
•••
Jim Wilkie
X
View Profile
View Bullboard History
Post by
Jim Wilkie
on Apr 23, 2024 4:26pm
@ the Bell: TSX joins upward movement among markets
Optimism spread across the globe's major markets Tuesday, including strong gains in the Toronto Stock Exchange.
read article.
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 18, 2024 8:31am
New Press Release - Soligenix Announces Pricing of $4.75 Million Public Offering
PRINCETON, N.J., April 18, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced the pricing of its...
read article.
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Apr 18, 2024 5:00am
Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions
Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 15, 2024 4:15pm
SGNX.....Now tell me....How did it go for all the Chasers
Now trading at 48 cents in AH I tried to warn you this a.m 10 mins after the opening bell ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Apr 15, 2024 10:42am
RE:SNGX.....in PB mode ...better hold L.O.D or else
Crash ....Booom....Bang....Oh u say the sky is falling? Nope ...just this Beotch....N.L.O.D
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 15, 2024 10:15am
Soligenix Granted Orphan Drug Designation for the Prevention
Breaking News: $SNGX Soligenix Granted Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection by FDA2024-04-15 08:01:00 ET DENVER, Colo., Apr
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 15, 2024 10:09am
SNGX.....in PB mode ...better hold L.O.D or else
Has to hold ~ $0.62 and rally
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 15, 2024 10:00am
FDA Grants Soligenix Orphan Drug Designation for the Prevent
Breaking News: $SNGX FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus InfectionFDA Grants Soligenix Orphan Drug Designation
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 15, 2024 9:40am
SNGX...another Orphan Drug grant by FDA? Yep
And this waiting for all the Chasers...... XBRL Viewer (sec.gov) How do you spell ....MONEY RAISE
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 01, 2023 7:30am
New Press Release - "HyBryte(TM) Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery
HyBryte™ has potential to address a critical gap in treatment of early-stage CTCLPRINCETON, N.J., Dec. 1, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 30, 2023 12:34pm
SNGX....Dang....Halted on the way up....Grrrrr
I coulda been a contenda
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 30, 2023 12:13pm
SNGX ....sold the starter position ; )
+ $0.30 cents /sh
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 30, 2023 11:54am
SNGX.....go down....I want some more ; )
Sheesh
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 30, 2023 11:47am
SNGX.... starter position ; )
~ $1.00
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 30, 2023 11:44am
SNGX ....Crash boom bang
Free falling....1.05
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 30, 2023 11:36am
SNGX.....Halted on the way down
Gotta back fill those gaps ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 30, 2023 9:17am
SNGX....early a.m runner up on NR
Soligenix Receives FDA IND Clearance for Phase 2 Clinical Trial of Dusquetide in the Treatment of Aphthous Ulcers in Beh ƒ §et's Disease 2023-11-30 04:30 ET - News Release Pipeline
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer